drugset / Trial / NCT07710326
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, multiple ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV261 tablets in healthy adults.
Timeline
- Start
- 2026-08-01
- Primary completion
- 2026-11-30
- Completion
- 2026-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VV261 | Unknown | 600 mg | Oral |
| Subject | VV261 | Unknown | 900 mg | Oral |
Indications
No indication recorded.